PNN
Vadodara (Gujarat) [India], December 17: Vadodara-based Gujarat Kidney and Super Speciality Limited is a multispecialist company providing healthcare services at several locations in Gujarat. The company is bringing an IPO on the NSE and BSE mainboard to meet its desired capital requirements for the proposed acquisition of Parekhs Hospital in Ahmedabad, partial payment of the purchase consideration for the already acquired "Ashwini Medical Center", financing the company's capital expenditure requirements for setting up a new hospital in Vadodara, purchase of robotics equipment for the Vadodara-based Gujarat Kidney and Super Speciality Hospital, full or partial repayment and/or prepayment of certain outstanding secured loans taken by the company, financing inorganic growth through unidentified acquisitions and general corporate purposes, and acquisition of additional shareholding in the Bharuch-based subsidiary "Harmony Medicare Private Limited". The Business Remedies team has obtained information regarding the company's business activities from the company's prospectus.
Business activities
Established in 2019, Gujarat Kidney and Super Speciality Limited (GKSL) specializes in providing multispeciality healthcare services at multiple locations in the state of Gujarat, India.
The company operates seven multispeciality hospitals and four pharmacies, with a total bed capacity of 490, an approved capacity of 455 beds, and an operational capacity of 340 beds.
The company's hospitals include Gujarat Kidney and Super Speciality Hospital (Vadodara), Gujarat Multispeciality Hospital (Godhra), Raj Pamland Hospital Private Limited (Bharuch), Surya Hospital and ICU (Borsad), Gujarat Surgical Hospital (Vadodara), and Ashwini Medical Center (Anand). The company also operates Ashwini Medical Store (Anand).
Company services
* Secondary care services: General and surgical treatments.
* Tertiary care services: Super-speciality surgical procedures.
Gujarat Super Speciality Hospital provides medical care in areas such as internal medicine, general surgery, minimally invasive procedures, orthopaedics and trauma care, joint replacement surgery, obstetrics and gynaecology, respiratory failure, non-interventional cardiology, diabetology, and anaesthesiology. As of June 30, 2025, the company employed 89 doctors, 332 nurses, and 338 other staff members.
Financial performance: In the financial year 2024, the company earned total revenue of Rs 5.48 crore and a profit after tax of Rs 1.71 crore, and in the financial year 2025, the company earned total revenue of Rs 40.40 crore and a profit after tax of Rs 9.50 crore. In the period ended June 30, 2025, of the financial year 2026, the company earned total revenue of Rs 15.27 crore and a profit after tax of Rs 5.40 crore. The financial results clearly indicate that the company's revenue and profit are increasing year on year. In the period ended June 30, 2025, of the financial year 2026, the company achieved a profit after tax margin of 35.41 per cent.
Information regarding the IPO: The IPO of Gujarat Kidney and Super Speciality Limited will open on December 22, 2025 and close on December 24, 2025, on the BSE and NSE mainboards. The company is issuing up to 2,20,00,000 shares of face value Rs 2 each. The IPO is being managed by the Book Running Lead Manager (BRLM), Nirbhay Capital Services Private Limited.
Note: This article is not investment advice.
(ADVERTORIAL DISCLAIMER: The above press release has been provided by PNN. ANI will not be responsible in any way for the content of the same.)